Loading…

Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells

Aims The purpose of this study was to analyse the expression of CD74 in human atherosclerotic plaques and peripheral blood mononuclear cells (PBMC) as well as its potential participation in proinflammatory responses in cultured human vascular smooth muscle cells (VSMC). Methods and results CD74 expr...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular research 2009-08, Vol.83 (3), p.586-594
Main Authors: Martín-Ventura, José Luis, Madrigal-Matute, Julio, Muñoz-Garcia, Begoña, Blanco-Colio, Luis Miguel, Van Oostrom, Melany, Zalba, Guillermo, Fortuño, Ana, Gomez-Guerrero, Carmen, Ortega, Luis, Ortiz, Alberto, Diez, Javier, Egido, Jesús
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c485t-b6a43a04fccced363f202373dca9420f22319fd8e3ad2a9313bf8e30257f1f3b3
cites cdi_FETCH-LOGICAL-c485t-b6a43a04fccced363f202373dca9420f22319fd8e3ad2a9313bf8e30257f1f3b3
container_end_page 594
container_issue 3
container_start_page 586
container_title Cardiovascular research
container_volume 83
creator Martín-Ventura, José Luis
Madrigal-Matute, Julio
Muñoz-Garcia, Begoña
Blanco-Colio, Luis Miguel
Van Oostrom, Melany
Zalba, Guillermo
Fortuño, Ana
Gomez-Guerrero, Carmen
Ortega, Luis
Ortiz, Alberto
Diez, Javier
Egido, Jesús
description Aims The purpose of this study was to analyse the expression of CD74 in human atherosclerotic plaques and peripheral blood mononuclear cells (PBMC) as well as its potential participation in proinflammatory responses in cultured human vascular smooth muscle cells (VSMC). Methods and results CD74 expression was analysed in human atherosclerotic plaques (immunohistochemistry), PBMC (real-time PCR), and human aortic VSMC (real-time PCR and western blotting). Nuclear factor-κB (NF-κB) activation was assessed by southwestern histochemistry and electrophoretic mobility shift assay. Monocyte chemoattractant protein-1 (MCP-1) levels were studied by both real-time PCR and enzyme-linked immunosorbent assay. CD74 immunostaining was increased in the inflammatory vs. the fibrous region of atherosclerotic plaques (n = 70, 18.2 ± 1.3 vs. 7.8 ± 0.6% positive staining/mm2, P < 0.001). CD74 colocalized with the transcription factor NF-κB in both VSMC and macrophages. In cultured VSMC, CD74 expression was induced by interferon γ (IFNγ). Incubation with an agonistic anti-CD74 antibody or with IFNγ elicited MCP-1 expression, which was prevented by AKT and γ-secretase inhibitors. Moreover, CD74 small-interfering RNA decreased NF-κB activation and MCP-1 production induced by IFNγ in VSMC. Finally, CD74 mRNA levels in PBMC from patients with carotid stenosis were higher than in healthy subjects (n = 20, 3 ± 0.5 vs. 2 ± 0.5 AU, P < 0.001). Additionally, a linear trend between CD74 mRNA expression tertiles and intima-media thickness (IMT) was observed in PBMC from asymptomatic subjects (n = 185, P < 0.001). Conclusion CD74 levels are increased in plaques and PBMC from patients with carotid stenosis and are associated with IMT in subjects free from clinical cardiovascular diseases. CD74 could be a novel therapeutic target to decrease the inflammatory response in atherosclerosis.
doi_str_mv 10.1093/cvr/cvp141
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67479596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cvr/cvp141</oup_id><sourcerecordid>67479596</sourcerecordid><originalsourceid>FETCH-LOGICAL-c485t-b6a43a04fccced363f202373dca9420f22319fd8e3ad2a9313bf8e30257f1f3b3</originalsourceid><addsrcrecordid>eNp9kE9rFTEUxYNY7LO68QNINnYhjCa5yfxxJ69qC68IpYq4CXcyCR2dmYxJprTf3gzv0e66SMKFX8495xDyhrMPnDXw0dyGfGYu-TOy4ZVSBQipnpMNY6wuSijhmLyM8U8elarkC3LMGymg5PWGpIvJBIvRdnR7Vklq7-ZgY-z9RPuJ3iwjThTTjQ0-miHfqTd0HvDfYuMnavyUQt8uacWTzz_cgOOIyYd7mmVmP0UbV6FbjGYZMFBjhyG-IkcOh2hfH94T8uPrl-vtebH7_u1i-3lXGFmrVLQlSkAmnTHGdjmGE0xABZ3B7J85IYA3rqstYCewAQ6tywMTqnLcQQsn5HSvOwe_Ok567OPqACfrl6jLSlaNasoMvt-DJueMwTo9h37EcK8502vHOnes9x1n-O1BdWlH2z2ih1Iz8O4A5NQ4uICT6eMDJ3jZ1HUDj5xf5qcXFnuuj8nePZAY_uYEUCl9_uu3vrq8vpI7dql_wn_vi6Qb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67479596</pqid></control><display><type>article</type><title>Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells</title><source>Oxford Journals Online</source><creator>Martín-Ventura, José Luis ; Madrigal-Matute, Julio ; Muñoz-Garcia, Begoña ; Blanco-Colio, Luis Miguel ; Van Oostrom, Melany ; Zalba, Guillermo ; Fortuño, Ana ; Gomez-Guerrero, Carmen ; Ortega, Luis ; Ortiz, Alberto ; Diez, Javier ; Egido, Jesús</creator><creatorcontrib>Martín-Ventura, José Luis ; Madrigal-Matute, Julio ; Muñoz-Garcia, Begoña ; Blanco-Colio, Luis Miguel ; Van Oostrom, Melany ; Zalba, Guillermo ; Fortuño, Ana ; Gomez-Guerrero, Carmen ; Ortega, Luis ; Ortiz, Alberto ; Diez, Javier ; Egido, Jesús</creatorcontrib><description>Aims The purpose of this study was to analyse the expression of CD74 in human atherosclerotic plaques and peripheral blood mononuclear cells (PBMC) as well as its potential participation in proinflammatory responses in cultured human vascular smooth muscle cells (VSMC). Methods and results CD74 expression was analysed in human atherosclerotic plaques (immunohistochemistry), PBMC (real-time PCR), and human aortic VSMC (real-time PCR and western blotting). Nuclear factor-κB (NF-κB) activation was assessed by southwestern histochemistry and electrophoretic mobility shift assay. Monocyte chemoattractant protein-1 (MCP-1) levels were studied by both real-time PCR and enzyme-linked immunosorbent assay. CD74 immunostaining was increased in the inflammatory vs. the fibrous region of atherosclerotic plaques (n = 70, 18.2 ± 1.3 vs. 7.8 ± 0.6% positive staining/mm2, P &lt; 0.001). CD74 colocalized with the transcription factor NF-κB in both VSMC and macrophages. In cultured VSMC, CD74 expression was induced by interferon γ (IFNγ). Incubation with an agonistic anti-CD74 antibody or with IFNγ elicited MCP-1 expression, which was prevented by AKT and γ-secretase inhibitors. Moreover, CD74 small-interfering RNA decreased NF-κB activation and MCP-1 production induced by IFNγ in VSMC. Finally, CD74 mRNA levels in PBMC from patients with carotid stenosis were higher than in healthy subjects (n = 20, 3 ± 0.5 vs. 2 ± 0.5 AU, P &lt; 0.001). Additionally, a linear trend between CD74 mRNA expression tertiles and intima-media thickness (IMT) was observed in PBMC from asymptomatic subjects (n = 185, P &lt; 0.001). Conclusion CD74 levels are increased in plaques and PBMC from patients with carotid stenosis and are associated with IMT in subjects free from clinical cardiovascular diseases. CD74 could be a novel therapeutic target to decrease the inflammatory response in atherosclerosis.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvp141</identifier><identifier>PMID: 19423618</identifier><identifier>CODEN: CVREAU</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Antigens, Differentiation, B-Lymphocyte - blood ; Antigens, Differentiation, B-Lymphocyte - genetics ; Antigens, Differentiation, B-Lymphocyte - metabolism ; Atherosclerosis ; Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Biomarkers ; Biomarkers - metabolism ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Carotid Arteries - immunology ; Carotid Arteries - pathology ; Carotid Arteries - surgery ; Carotid stenosis ; Carotid Stenosis - immunology ; Carotid Stenosis - pathology ; Carotid Stenosis - surgery ; Case-Control Studies ; Cells, Cultured ; Chemokine CCL2 - metabolism ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Endarterectomy, Carotid ; Fibrosis ; Histocompatibility Antigens Class II - blood ; Histocompatibility Antigens Class II - genetics ; Histocompatibility Antigens Class II - metabolism ; Humans ; Inflammation ; Inflammation - immunology ; Inflammation - pathology ; Inflammation Mediators - blood ; Inflammation Mediators - metabolism ; Interferon-gamma - metabolism ; Leukocytes, Mononuclear - immunology ; Macrophages - immunology ; Medical sciences ; Muscle, Smooth, Vascular - immunology ; Muscle, Smooth, Vascular - pathology ; Muscle, Smooth, Vascular - surgery ; Myocytes, Smooth Muscle - immunology ; Myocytes, Smooth Muscle - pathology ; Neurology ; NF-kappa B - metabolism ; Recombinant Proteins - metabolism ; RNA Interference ; Severity of Illness Index ; Time Factors ; Transfection ; Tumor Necrosis Factor-alpha - metabolism ; Tunica Intima - immunology ; Tunica Media - immunology ; Up-Regulation ; Vascular diseases and vascular malformations of the nervous system</subject><ispartof>Cardiovascular research, 2009-08, Vol.83 (3), p.586-594</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org. 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c485t-b6a43a04fccced363f202373dca9420f22319fd8e3ad2a9313bf8e30257f1f3b3</citedby><cites>FETCH-LOGICAL-c485t-b6a43a04fccced363f202373dca9420f22319fd8e3ad2a9313bf8e30257f1f3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21698893$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19423618$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martín-Ventura, José Luis</creatorcontrib><creatorcontrib>Madrigal-Matute, Julio</creatorcontrib><creatorcontrib>Muñoz-Garcia, Begoña</creatorcontrib><creatorcontrib>Blanco-Colio, Luis Miguel</creatorcontrib><creatorcontrib>Van Oostrom, Melany</creatorcontrib><creatorcontrib>Zalba, Guillermo</creatorcontrib><creatorcontrib>Fortuño, Ana</creatorcontrib><creatorcontrib>Gomez-Guerrero, Carmen</creatorcontrib><creatorcontrib>Ortega, Luis</creatorcontrib><creatorcontrib>Ortiz, Alberto</creatorcontrib><creatorcontrib>Diez, Javier</creatorcontrib><creatorcontrib>Egido, Jesús</creatorcontrib><title>Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Aims The purpose of this study was to analyse the expression of CD74 in human atherosclerotic plaques and peripheral blood mononuclear cells (PBMC) as well as its potential participation in proinflammatory responses in cultured human vascular smooth muscle cells (VSMC). Methods and results CD74 expression was analysed in human atherosclerotic plaques (immunohistochemistry), PBMC (real-time PCR), and human aortic VSMC (real-time PCR and western blotting). Nuclear factor-κB (NF-κB) activation was assessed by southwestern histochemistry and electrophoretic mobility shift assay. Monocyte chemoattractant protein-1 (MCP-1) levels were studied by both real-time PCR and enzyme-linked immunosorbent assay. CD74 immunostaining was increased in the inflammatory vs. the fibrous region of atherosclerotic plaques (n = 70, 18.2 ± 1.3 vs. 7.8 ± 0.6% positive staining/mm2, P &lt; 0.001). CD74 colocalized with the transcription factor NF-κB in both VSMC and macrophages. In cultured VSMC, CD74 expression was induced by interferon γ (IFNγ). Incubation with an agonistic anti-CD74 antibody or with IFNγ elicited MCP-1 expression, which was prevented by AKT and γ-secretase inhibitors. Moreover, CD74 small-interfering RNA decreased NF-κB activation and MCP-1 production induced by IFNγ in VSMC. Finally, CD74 mRNA levels in PBMC from patients with carotid stenosis were higher than in healthy subjects (n = 20, 3 ± 0.5 vs. 2 ± 0.5 AU, P &lt; 0.001). Additionally, a linear trend between CD74 mRNA expression tertiles and intima-media thickness (IMT) was observed in PBMC from asymptomatic subjects (n = 185, P &lt; 0.001). Conclusion CD74 levels are increased in plaques and PBMC from patients with carotid stenosis and are associated with IMT in subjects free from clinical cardiovascular diseases. CD74 could be a novel therapeutic target to decrease the inflammatory response in atherosclerosis.</description><subject>Antigens, Differentiation, B-Lymphocyte - blood</subject><subject>Antigens, Differentiation, B-Lymphocyte - genetics</subject><subject>Antigens, Differentiation, B-Lymphocyte - metabolism</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Biomarkers - metabolism</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Carotid Arteries - immunology</subject><subject>Carotid Arteries - pathology</subject><subject>Carotid Arteries - surgery</subject><subject>Carotid stenosis</subject><subject>Carotid Stenosis - immunology</subject><subject>Carotid Stenosis - pathology</subject><subject>Carotid Stenosis - surgery</subject><subject>Case-Control Studies</subject><subject>Cells, Cultured</subject><subject>Chemokine CCL2 - metabolism</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Endarterectomy, Carotid</subject><subject>Fibrosis</subject><subject>Histocompatibility Antigens Class II - blood</subject><subject>Histocompatibility Antigens Class II - genetics</subject><subject>Histocompatibility Antigens Class II - metabolism</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Inflammation - immunology</subject><subject>Inflammation - pathology</subject><subject>Inflammation Mediators - blood</subject><subject>Inflammation Mediators - metabolism</subject><subject>Interferon-gamma - metabolism</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Macrophages - immunology</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - immunology</subject><subject>Muscle, Smooth, Vascular - pathology</subject><subject>Muscle, Smooth, Vascular - surgery</subject><subject>Myocytes, Smooth Muscle - immunology</subject><subject>Myocytes, Smooth Muscle - pathology</subject><subject>Neurology</subject><subject>NF-kappa B - metabolism</subject><subject>Recombinant Proteins - metabolism</subject><subject>RNA Interference</subject><subject>Severity of Illness Index</subject><subject>Time Factors</subject><subject>Transfection</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Tunica Intima - immunology</subject><subject>Tunica Media - immunology</subject><subject>Up-Regulation</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kE9rFTEUxYNY7LO68QNINnYhjCa5yfxxJ69qC68IpYq4CXcyCR2dmYxJprTf3gzv0e66SMKFX8495xDyhrMPnDXw0dyGfGYu-TOy4ZVSBQipnpMNY6wuSijhmLyM8U8elarkC3LMGymg5PWGpIvJBIvRdnR7Vklq7-ZgY-z9RPuJ3iwjThTTjQ0-miHfqTd0HvDfYuMnavyUQt8uacWTzz_cgOOIyYd7mmVmP0UbV6FbjGYZMFBjhyG-IkcOh2hfH94T8uPrl-vtebH7_u1i-3lXGFmrVLQlSkAmnTHGdjmGE0xABZ3B7J85IYA3rqstYCewAQ6tywMTqnLcQQsn5HSvOwe_Ok567OPqACfrl6jLSlaNasoMvt-DJueMwTo9h37EcK8502vHOnes9x1n-O1BdWlH2z2ih1Iz8O4A5NQ4uICT6eMDJ3jZ1HUDj5xf5qcXFnuuj8nePZAY_uYEUCl9_uu3vrq8vpI7dql_wn_vi6Qb</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Martín-Ventura, José Luis</creator><creator>Madrigal-Matute, Julio</creator><creator>Muñoz-Garcia, Begoña</creator><creator>Blanco-Colio, Luis Miguel</creator><creator>Van Oostrom, Melany</creator><creator>Zalba, Guillermo</creator><creator>Fortuño, Ana</creator><creator>Gomez-Guerrero, Carmen</creator><creator>Ortega, Luis</creator><creator>Ortiz, Alberto</creator><creator>Diez, Javier</creator><creator>Egido, Jesús</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090801</creationdate><title>Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells</title><author>Martín-Ventura, José Luis ; Madrigal-Matute, Julio ; Muñoz-Garcia, Begoña ; Blanco-Colio, Luis Miguel ; Van Oostrom, Melany ; Zalba, Guillermo ; Fortuño, Ana ; Gomez-Guerrero, Carmen ; Ortega, Luis ; Ortiz, Alberto ; Diez, Javier ; Egido, Jesús</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c485t-b6a43a04fccced363f202373dca9420f22319fd8e3ad2a9313bf8e30257f1f3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antigens, Differentiation, B-Lymphocyte - blood</topic><topic>Antigens, Differentiation, B-Lymphocyte - genetics</topic><topic>Antigens, Differentiation, B-Lymphocyte - metabolism</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Biomarkers - metabolism</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Carotid Arteries - immunology</topic><topic>Carotid Arteries - pathology</topic><topic>Carotid Arteries - surgery</topic><topic>Carotid stenosis</topic><topic>Carotid Stenosis - immunology</topic><topic>Carotid Stenosis - pathology</topic><topic>Carotid Stenosis - surgery</topic><topic>Case-Control Studies</topic><topic>Cells, Cultured</topic><topic>Chemokine CCL2 - metabolism</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Endarterectomy, Carotid</topic><topic>Fibrosis</topic><topic>Histocompatibility Antigens Class II - blood</topic><topic>Histocompatibility Antigens Class II - genetics</topic><topic>Histocompatibility Antigens Class II - metabolism</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Inflammation - immunology</topic><topic>Inflammation - pathology</topic><topic>Inflammation Mediators - blood</topic><topic>Inflammation Mediators - metabolism</topic><topic>Interferon-gamma - metabolism</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Macrophages - immunology</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - immunology</topic><topic>Muscle, Smooth, Vascular - pathology</topic><topic>Muscle, Smooth, Vascular - surgery</topic><topic>Myocytes, Smooth Muscle - immunology</topic><topic>Myocytes, Smooth Muscle - pathology</topic><topic>Neurology</topic><topic>NF-kappa B - metabolism</topic><topic>Recombinant Proteins - metabolism</topic><topic>RNA Interference</topic><topic>Severity of Illness Index</topic><topic>Time Factors</topic><topic>Transfection</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Tunica Intima - immunology</topic><topic>Tunica Media - immunology</topic><topic>Up-Regulation</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martín-Ventura, José Luis</creatorcontrib><creatorcontrib>Madrigal-Matute, Julio</creatorcontrib><creatorcontrib>Muñoz-Garcia, Begoña</creatorcontrib><creatorcontrib>Blanco-Colio, Luis Miguel</creatorcontrib><creatorcontrib>Van Oostrom, Melany</creatorcontrib><creatorcontrib>Zalba, Guillermo</creatorcontrib><creatorcontrib>Fortuño, Ana</creatorcontrib><creatorcontrib>Gomez-Guerrero, Carmen</creatorcontrib><creatorcontrib>Ortega, Luis</creatorcontrib><creatorcontrib>Ortiz, Alberto</creatorcontrib><creatorcontrib>Diez, Javier</creatorcontrib><creatorcontrib>Egido, Jesús</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martín-Ventura, José Luis</au><au>Madrigal-Matute, Julio</au><au>Muñoz-Garcia, Begoña</au><au>Blanco-Colio, Luis Miguel</au><au>Van Oostrom, Melany</au><au>Zalba, Guillermo</au><au>Fortuño, Ana</au><au>Gomez-Guerrero, Carmen</au><au>Ortega, Luis</au><au>Ortiz, Alberto</au><au>Diez, Javier</au><au>Egido, Jesús</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>83</volume><issue>3</issue><spage>586</spage><epage>594</epage><pages>586-594</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><coden>CVREAU</coden><abstract>Aims The purpose of this study was to analyse the expression of CD74 in human atherosclerotic plaques and peripheral blood mononuclear cells (PBMC) as well as its potential participation in proinflammatory responses in cultured human vascular smooth muscle cells (VSMC). Methods and results CD74 expression was analysed in human atherosclerotic plaques (immunohistochemistry), PBMC (real-time PCR), and human aortic VSMC (real-time PCR and western blotting). Nuclear factor-κB (NF-κB) activation was assessed by southwestern histochemistry and electrophoretic mobility shift assay. Monocyte chemoattractant protein-1 (MCP-1) levels were studied by both real-time PCR and enzyme-linked immunosorbent assay. CD74 immunostaining was increased in the inflammatory vs. the fibrous region of atherosclerotic plaques (n = 70, 18.2 ± 1.3 vs. 7.8 ± 0.6% positive staining/mm2, P &lt; 0.001). CD74 colocalized with the transcription factor NF-κB in both VSMC and macrophages. In cultured VSMC, CD74 expression was induced by interferon γ (IFNγ). Incubation with an agonistic anti-CD74 antibody or with IFNγ elicited MCP-1 expression, which was prevented by AKT and γ-secretase inhibitors. Moreover, CD74 small-interfering RNA decreased NF-κB activation and MCP-1 production induced by IFNγ in VSMC. Finally, CD74 mRNA levels in PBMC from patients with carotid stenosis were higher than in healthy subjects (n = 20, 3 ± 0.5 vs. 2 ± 0.5 AU, P &lt; 0.001). Additionally, a linear trend between CD74 mRNA expression tertiles and intima-media thickness (IMT) was observed in PBMC from asymptomatic subjects (n = 185, P &lt; 0.001). Conclusion CD74 levels are increased in plaques and PBMC from patients with carotid stenosis and are associated with IMT in subjects free from clinical cardiovascular diseases. CD74 could be a novel therapeutic target to decrease the inflammatory response in atherosclerosis.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>19423618</pmid><doi>10.1093/cvr/cvp141</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-6363
ispartof Cardiovascular research, 2009-08, Vol.83 (3), p.586-594
issn 0008-6363
1755-3245
language eng
recordid cdi_proquest_miscellaneous_67479596
source Oxford Journals Online
subjects Antigens, Differentiation, B-Lymphocyte - blood
Antigens, Differentiation, B-Lymphocyte - genetics
Antigens, Differentiation, B-Lymphocyte - metabolism
Atherosclerosis
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Biomarkers
Biomarkers - metabolism
Blood and lymphatic vessels
Cardiology. Vascular system
Carotid Arteries - immunology
Carotid Arteries - pathology
Carotid Arteries - surgery
Carotid stenosis
Carotid Stenosis - immunology
Carotid Stenosis - pathology
Carotid Stenosis - surgery
Case-Control Studies
Cells, Cultured
Chemokine CCL2 - metabolism
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Endarterectomy, Carotid
Fibrosis
Histocompatibility Antigens Class II - blood
Histocompatibility Antigens Class II - genetics
Histocompatibility Antigens Class II - metabolism
Humans
Inflammation
Inflammation - immunology
Inflammation - pathology
Inflammation Mediators - blood
Inflammation Mediators - metabolism
Interferon-gamma - metabolism
Leukocytes, Mononuclear - immunology
Macrophages - immunology
Medical sciences
Muscle, Smooth, Vascular - immunology
Muscle, Smooth, Vascular - pathology
Muscle, Smooth, Vascular - surgery
Myocytes, Smooth Muscle - immunology
Myocytes, Smooth Muscle - pathology
Neurology
NF-kappa B - metabolism
Recombinant Proteins - metabolism
RNA Interference
Severity of Illness Index
Time Factors
Transfection
Tumor Necrosis Factor-alpha - metabolism
Tunica Intima - immunology
Tunica Media - immunology
Up-Regulation
Vascular diseases and vascular malformations of the nervous system
title Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A17%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20CD74%20expression%20in%20human%20atherosclerotic%20plaques:%20contribution%20to%20inflammatory%20responses%20in%20vascular%20cells&rft.jtitle=Cardiovascular%20research&rft.au=Mart%C3%ADn-Ventura,%20Jos%C3%A9%20Luis&rft.date=2009-08-01&rft.volume=83&rft.issue=3&rft.spage=586&rft.epage=594&rft.pages=586-594&rft.issn=0008-6363&rft.eissn=1755-3245&rft.coden=CVREAU&rft_id=info:doi/10.1093/cvr/cvp141&rft_dat=%3Cproquest_cross%3E67479596%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c485t-b6a43a04fccced363f202373dca9420f22319fd8e3ad2a9313bf8e30257f1f3b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67479596&rft_id=info:pmid/19423618&rft_oup_id=10.1093/cvr/cvp141&rfr_iscdi=true